Zhang Kexin, Zhang Qi, Qiu Hongyan, Ma Yanhui, Hou Ningning, Zhang Jingwen, Kan Chengxia, Han Fang, Sun Xiaodong, Shi Junfeng
Department of Endocrinology and Metabolism, Affiliated Hospital of Shandong Second Medical University, School of Clinical Medicine, Shandong Second Medical University, Weifang, China.
Clinical Research Center, Affiliated Hospital of Shandong Second Medical University, Weifang, China.
Heliyon. 2024 Sep 7;10(17):e37609. doi: 10.1016/j.heliyon.2024.e37609. eCollection 2024 Sep 15.
Microbial interactions are widespread and important processes that support the link between disease and microbial ecology. The gut microbiota is a major source of microbial stimuli that can have detrimental or beneficial effects on human health. It is also an endocrine organ that maintains energy homeostasis and host immunity. Obesity is a highly and increasingly prevalent metabolic disease and the leading cause of preventable death worldwide. An imbalance in the gut microbiome is associated with several diseases including obesity-related metabolic disorders. This review summarizes the complex association between the gut microbiome and obesity-associated metabolic diseases and validates the role and mechanisms of ecological dysregulation in the gut in obesity-associated metabolic disorders. Therapies that could potentially alleviate obesity-associated metabolic diseases by modulating the gut microbiota are discussed.
微生物相互作用是广泛且重要的过程,它支撑着疾病与微生物生态学之间的联系。肠道微生物群是微生物刺激的主要来源,对人类健康可能产生有害或有益的影响。它也是一个维持能量稳态和宿主免疫的内分泌器官。肥胖是一种高度流行且日益普遍的代谢性疾病,是全球可预防死亡的主要原因。肠道微生物群失衡与包括肥胖相关代谢紊乱在内的多种疾病有关。本综述总结了肠道微生物群与肥胖相关代谢疾病之间的复杂关联,并验证了肠道生态失调在肥胖相关代谢紊乱中的作用和机制。还讨论了可能通过调节肠道微生物群来缓解肥胖相关代谢疾病的疗法。